目前用于患有注意力缺陷/多动症障碍的成年人的非刺激药物
Giulio Emilio Brancati1, Anna Magnesa1, Donatella Acierno1
1Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy.
非兴奋剂药物为那些对传统兴奋剂没有反应的注意力缺陷多动症 (ADHD) 的成年人提供了有效的替代品. 研究强调了阿托莫克赛丁和其他药物用于个性化ADHD治疗.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 像甲基酸盐和安非他胺这样的兴奋剂是成人多动症的主要治疗方法.
- 对于对兴奋剂反应或耐受性较差的患者,非兴奋剂选择至关重要.
研究的目的:
- 审查成人ADHD的非兴奋剂治疗方法.
- 总结各种非兴奋剂药物的疗效,剂量,安全性和并发性考虑因素.
主要方法:
- 对成年ADHD样本的受控和观察性临床研究的叙事文献综述.
- 关于阿托莫克赛丁,抗抑郁药,抗高血压药和其他药物的综合证据.
主要成果:
- 阿托莫克赛丁在成人多动症治疗中表现出显著的疗效.
- 抗抑郁药 (noradrenergic/dopaminergic),guanfacine,memantine,metadoxine以及情绪稳定剂显示出有效性.
- 加兰塔明,抗精神病药物和大麻素产生了负面的结果.
结论:
- 阿托莫克赛丁是关键的二线选择,但其他非兴奋剂允许个性化ADHD治疗.
- 针对成人多动症的量身定制治疗策略需要进一步的研究.
更多相关视频
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
相关概念视频
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Antidepressant Drugs: MAOIs and Other Agents
Drug Therapy
Antianxiety Medications
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
